Skip to content
EmergingResearch compound

Mibolerone (Cheque Drops)

Veterinary steroid made to suppress heat in female dogs; not studied in people and very damaging to the liver.

Available at
DEUSPOWER logo
DEUSPOWERProduct page

The links above are labelled third-party affiliate links. MolekulaX does not sell and does not verify product quality.

Mibolerone (Cheque Drops) vial

DETAILED OVERVIEW

What is Mibolerone (Cheque Drops)?

Mibolerone (Cheque Drops) is an extremely potent steroid of the male-hormone type, developed as a veterinary product to suppress heat in female dogs; it has since been withdrawn from several markets. It has never been approved as a human medicine and has not been studied in people. Among bodybuilders it spread as an aggression booster before competition or heavy lifting.

It puts a heavy load on the liver, and in dogs prolonged use caused liver changes. The aggression and irritability it causes cannot be controlled, and the risk cannot be estimated. It shuts down the body's own testosterone production, and recovery can take weeks to months. In dogs, tumors of the ovary were described with prolonged use; this cannot be applied directly to humans, but it cannot be ignored either. It is so potent that an error in dilution or measuring can lead to a serious overdose. It must not be used in pregnancy, because it causes masculinization of the fetus. It is banned in competitive sport all year round.

Original purpose

A veterinary product for suppressing estrus in bitches.

Human trials

None. Never approved for human therapeutic use.

Main risks

Marked hepatotoxicity, complete HPTA suppression, tumour risk described in dogs.

Legal status

No human drug approval. WADA-banned year-round (S1).

Data console

Lab data

Androgenic:AnabolicExtremely high androgenic activity. No anabolic-to-androgenic ratio based on human data is available.
AR bindingA high affinity agonist of the androgen receptor with…
Active half-life~4 h (becsült)
Detection windowIts metabolites are identified by mass spectrometry; Williams 2000 developed the method for greyhound doping control. To be avoided by tested athletes.
AromatizationNOT significant. The 19-nor skeleton does not meaningfully convert to estradiol, but progesterone receptor activity can produce prolactin-type adverse effects.
HepatotoxicityHIGH. The 17-alpha-methyl group imposes a substantial hepatic load, and prolonged dosing produced hepatic changes in dogs. It cannot be used without regular liver enzyme monitoring.

Safety

Side effects, stop signs, contraindications

Side effects · 5

  • Severe liver injury: markedly hepatotoxic due to the 17-alpha-methyl group; prolonged dosing produced hepatic changes in dogs.
  • Marked aggression and irritability: this is precisely why it is used in some circles, but the effect is uncontrollable and its risk cannot be estimated.
  • Tumour risk: ovarian fibroma was described in a long-term canine study after prolonged mibolerone exposure (Seaman 1985).
  • HPTA suppression: endogenous testosterone production shuts down, recovery can take weeks to months and may require post-cycle therapy.
  • Lipid deterioration: falling HDL cholesterol is a class effect of androgens and implies cardiovascular risk with prolonged use.

Contraindications · 4

  • Existing liver disease or elevated baseline ALT/AST: absolute contraindication.
  • Dyslipidemia or existing cardiovascular disease: androgens worsen the lipid profile.
  • Pregnancy and breastfeeding: androgenic action causes fetal virilization, use is prohibited.
  • Competitive sport under testing: WADA bans anabolic agents year-round (S1).

Related Performance Compounds

Same therapeutic category

Studies

Related research and clinical findings

Telegram

Have a question about Mibolerone (Cheque Drops)?

Reach out to an advisor on Telegram. Performance compounds are presented with a harm-reduction approach, based on peer-reviewed evidence.

Personalized consultation

Want a detailed conversation tailored to your data?

Fill out the prep intake form (your goals, training and health data), and the advisor prepares from it to give genuinely personalized guidance.

Fill out the form

~5–7 min · prep questionnaire · confidential · GDPR-compliant

MolekulaX Editorial Team·Source-verified · PubMed · FDA · EMA
Updated: October 13, 2026

The information here is for educational and scientific purposes only. Performance-enhancing compounds (AAS, prohormones, stimulants, doping agents) are illegal without prescription in Hungary and most of the EU, and carry serious health and legal risks. WADA bans them in competitive sport. This is NOT a usage guide, and we do not encourage any illegal use. If you do use them, medical supervision and regular bloodwork are ESSENTIAL. Severe endocrine, cardiovascular, hepatic and psychiatric side effects are possible.